by rss feed | Dec 22, 2020 | COVID-19, Mesoblast, News Feeds, Remestemcel-l, stem cell clinical trials, Stem cells for COVID-19
I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are...
by rss feed | Oct 27, 2020 | IPS cells, IPS cells disease modeling, IPSC, IPSCs, Jun Takahashi, News Feeds, Shinya Yamanaka, stem cell clinical trials, stem cells for Parkinsons, Takanori Takebe, Takayuki Kikuchi
IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be...
by rss feed | Oct 27, 2020 | IPS cells, IPS cells disease modeling, IPSC, IPSCs, Jun Takahashi, News Feeds, Shinya Yamanaka, stem cell clinical trials, stem cells for Parkinsons, Takanori Takebe, Takayuki Kikuchi
IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be...
